OptimizeRx (OPRX) Depreciation & Amortization (IS) (2022 - 2026)

OptimizeRx's Depreciation & Amortization (IS) history runs 5 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• In Q1 2026, Depreciation & Amortization (IS) fell 2.74% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $4.3 million (down 1.38% YoY), while the FY2025 annual figure was $4.3 million, changed 0.05% from the prior year.
• Depreciation & Amortization (IS) came in at $1.1 million for Q1 2026 at OptimizeRx, down from $1.1 million in the prior quarter.
• In the past five years, Depreciation & Amortization (IS) ranged from a high of $1.1 million in Q3 2024 to a low of $456545.0 in Q4 2022.
• A 5-year average of $832001.8 and a median of $1.1 million in 2026 frame the typical range for Depreciation & Amortization (IS).
• Across the five-year window, Depreciation & Amortization (IS) fell 19.57% in 2023 and jumped 134.48% in 2024, its largest moves.
• OptimizeRx's Depreciation & Amortization (IS) stood at $456545.0 in 2022, then soared by 120.57% to $1.0 million in 2023, then climbed by 8.64% to $1.1 million in 2024, then fell by 1.46% to $1.1 million in 2025, then dropped by 1.3% to $1.1 million in 2026.
• According to Business Quant data, Depreciation & Amortization (IS) over the past three periods registered $1.1 million, $1.1 million, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison